Visceral Adipose Tissue-Derived Serine Protease Inhibitor Accelerates Cholesterol Efflux by Up-Regulating ABCA1 Expression Via the NF-κB/miR-33a Pathway in THP-1 Macropahge-Derived Foam Cells

Jia-Hui Gao,Meng-Ya Zeng,Xiao-Hua Yu,Gao-Feng Zeng,Lin-Hao He,Xi-Long Zheng,Da-Wei Zhang,Xin-Ping Ouyang,Chao-Ke Tang

DOI: https://doi.org/10.1016/j.bbrc.2018.04.066

IF: 3.1

2018-01-01

Biochemical and Biophysical Research Communications

Abstract:Atherosclerosis is a dyslipidemia disease characterized by foam cell formation driven by the accumulation of lipids. Visceral adipose tissue-derived serine protease inhibitor (vaspin) is known to suppress the development of atherosclerosis via its anti-inflammatory properties, but it is not yet known whether vaspin affects cholesterol efflux in THP-1 macrophage-derived foam cells. Here, we investigated the effects of vaspin on ABCA1 expression and cholesterol efflux, and further explored the underlying mechanism. We found that vaspin decreased miR-33a levels, which in turn increased ABCA1 expression and cholesteorl efflux. We also found that inhibition of NF-κB reduced miR-33a expression and vaspin suppressed LPS-mediated NF-κB phosphorylation. Our findings suggest that vaspin is not only a regular of inflammasion but also a promoter of cholesterol efflux.